Compare EPOW & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EPOW | MODD |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 30.6M |
| IPO Year | 2021 | N/A |
| Metric | EPOW | MODD |
|---|---|---|
| Price | $0.91 | $0.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 146.3K | ★ 301.5K |
| Earning Date | 05-15-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,681,651.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 51.60 | N/A |
| 52 Week Low | $0.76 | $0.28 |
| 52 Week High | $1.86 | $1.35 |
| Indicator | EPOW | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 56.62 |
| Support Level | $0.90 | $0.45 |
| Resistance Level | $1.03 | $0.53 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 5.97 | 64.17 |
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.